We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.51 | -1.68% | 29.82 | 29.82 | 30.03 | 30.15 | 29.81 | 29.92 | 3,381,439 | 21:00:05 |
From May 2019 to May 2024
By Pietro Lombardi
Roche Holding AG (ROG.EB) and Spark Therapeutics Inc. (ONCE) said Wednesday that Roche is extending the offer period for Spark after it withdrew the premerger notification and report form related to the acquisition.
The move comes under the Hart-Scott-Rodino Act, the companies said, and Roche intends to refile around April 10.
"As a result of the withdrawal and refiling of the premerger notification and report form, Roche is extending the offering period of its previously announced tender offer to purchase all of the outstanding shares of common stock of Spark," the companies said.
The offer now expires on May 2.
As of April 2, roughly 29.4% of Spark's outstanding shares had been tendered.
Write to Pietro Lombardi at pietro.lombardi@dowjones.com
(END) Dow Jones Newswires
April 03, 2019 01:35 ET (05:35 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
